Companion Diagnostics and Liquid Biopsy drive market growth. New cancer diagnostic segments emerging
After a pandemic interruption the market for Cancer Molecular Diagnostics is back on the growth path. And growth is accelerating in every segment. We include a special segment Cancer Companion Diagnostics, a new segment of the market that is reshaping the industry. Over 120 companies are profiled. A range of dynamic trends are pushing market growth and company valuations.
Trends like:
- personalized medicine
- pharmacogenomics
- liquid biopsy
- minimal residual disease testing
- emergence of new economies with large markets
- physician diagnostics being displaced by new intelligent diagnostic tests
Exciting technical developments especially in companion diagnostics, hold the promise of a dynamic, growing and evolving world market where single laboratories serve a global patient base.
In addition customization work, breakouts for particular segments, assistance and support is included free of charge with every report.
Molecular Diagnostics for Cancer. Markets Forecasts by Cancer Type, Product and Place with Executive and Consultant Guides and Customization provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help understand test pricing in detail. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.
Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities' growth. Again, assistance in using the information is normally provided without additional charges.
The report includes detailed breakouts for 18 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
Table of Contents
Companies Mentioned
- 10x Genomics, Inc.
- Abbott Laboratories
- AccuraGen Inc.
- Adaptive Biotechnologies
- Aethlon Medical
- Agilent/Dako
- Anchor Dx
- ANGLE plc
- ARUP Laboratories
- AVIVA Systems Biology
- Baylor Miraca Genetics Laboratories
- Beckman Coulter Diagnostics
- Becton, Dickinson and Company
- BGI Genomics CoLtd
- BillionToOne
- Bioarray Genetics
- Biocartis
- Biocept, Inc.
- Biodesix Inc.
- BioFluidica
- BioGenex
- BioIVT
- Biolidics Ltd
- bioMérieux Diagnostics
- Bioneer Corporation
- Bio-Rad Laboratories, Inc
- Bio-Reference Laboratories
- Bio-Techne
- Bioview
- Bolidics
- Boreal Genomics
- Bristol-Myers Squibb
- Burning Rock
- Cardiff Oncology
- Caris Molecular Diagnostics
- Castle Biosciences, Inc.
- Celemics
- CellCarta
- CellMax Life
- Cepheid (Danaher)
- Charles River Laboratories
- Circulogene
- Cizzle Biotech
- Clinical Genomics
- Cytolumina Technologies Corp.
- Datar Cancer Genetics Limited
- Diagnologix LLC
- Diasorin S.p.A.
- Dxcover
- Enzo Biochem
- Epic Sciences
- Epigenomics AG
- Eurofins Scientific
- Exact Sciences
- Fabric Genomics
- Fluxion Biosciences
- Freenome
- FUJIFILM Wako Diagnostics
- Fulgent Genetics
- Fyr Diagnostics
- GeneFirst Ltd.
- Genetron Holdings
- GenomOncology
- GILUPI Nanomedizin
- Guardant Health
- HansaBiomed
- HeiScreen
- Helomics
- HTG Molecular Diagnostics
- iCellate
- ICON PLC
- Illumina
- Incell Dx
- Inivata
- INOVIQ
- Integrated Diagnostics
- Invitae Corporation
- Invivogen
- Invivoscribe
- Janssen Diagnostics
- Lunglife AI Inc
- MDNA Life SCIENCES, Inc.
- MDx Health
- Menarini Silicon Biosystems
- Mesa Laboratories, Inc.
- Millipore Sigma
- Miltenyi Biotec
- miR Scientific
- Myriad Genetics/Myriad RBM
- NantHealth, Inc.
- Natera
- NeoGenomics
- NGeneBio
- Novogene Bioinformatics Technology Co., Ltd.
- Oncocyte
- OncoDNA
- Ortho Clinical Diagnostics
- Oxford Nanopore Technologies
- PamGene
- Panagene
- Perkin Elmer
- Personal Genome Diagnostics
- Personalis
- Precipio
- Precision Medicine Group
- PrecisionMed
- Predicine
- Promega
- Qiagen
- Rarecells SAS
- RareCyte
- Roche Molecular Diagnostics
- Screencell
- Sema4 Holdings
- Sense Biodetection
- Siemens Healthineers
- simfo GmbH
- Singlera Genomics Inc.
- Singulomics
- SkylineDx
- Standard BioTools
- Sysmex Inostics
- Tempus Labs, Inc.
- Thermo Fisher Scientific Inc.
- Todos Medical
- Variantyx
- Veracyte
- Volition
- Vortex Biosciences
- Vyant Bio
- Zhejiang Orient Gene Biotech